{"title":"HD Labs","description":null,"products":[{"product_id":"hd-labs-retatrutide-32mg-vial","title":"HD Labs Retatrutide 32mg Vial","description":"\u003cp data-start=\"379\" data-end=\"617\"\u003eRetatrutide is a peptide currently under advanced clinical investigation for its activity across multiple metabolic pathways. It is designed to act on\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"549\" data-end=\"614\"\u003ethree key receptors involved in glucose and energy regulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul data-start=\"618\" data-end=\"731\"\u003e\n\u003cli data-start=\"618\" data-end=\"653\"\u003e\n\u003cp data-start=\"620\" data-end=\"653\"\u003eGLP-1 (glucagon-like peptide-1)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"654\" data-end=\"708\"\u003e\n\u003cp data-start=\"656\" data-end=\"708\"\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"709\" data-end=\"731\"\u003e\n\u003cp data-start=\"711\" data-end=\"731\"\u003eGlucagon receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"733\" data-end=\"927\"\u003eThrough this\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"746\" data-end=\"774\"\u003etriple-agonist mechanism\u003c\/strong\u003e, retatrutide has been studied for its effects on insulin secretion, regulation of glucose production, gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003chr data-start=\"929\" data-end=\"932\"\u003e\n\u003ch3 data-start=\"934\" data-end=\"959\"\u003eClinical Trial Status\u003c\/h3\u003e\n\u003cp data-start=\"960\" data-end=\"1077\"\u003eAs of\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"966\" data-end=\"974\"\u003e2025\u003c\/strong\u003e, retatrutide remains\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"996\" data-end=\"1052\"\u003eunder investigation and is not yet formally approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor general medical use.\u003c\/p\u003e\n\u003cul data-start=\"1079\" data-end=\"1534\"\u003e\n\u003cli data-start=\"1079\" data-end=\"1280\"\u003e\n\u003cp data-start=\"1081\" data-end=\"1280\"\u003e\u003cstrong data-start=\"1081\" data-end=\"1109\"\u003ePhase 2 clinical studies\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereported significant outcomes, with participants experiencing an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1175\" data-end=\"1245\"\u003eaverage body-weight reduction of approximately 24.2% over 48 weeks\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eunder controlled trial conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1281\" data-end=\"1534\"\u003e\n\u003cp data-start=\"1283\" data-end=\"1534\"\u003e\u003cstrong data-start=\"1283\" data-end=\"1310\"\u003ePhase 3 clinical trials\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare ongoing and have reported\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1341\" data-end=\"1422\"\u003econtinued, clinically meaningful effects consistent with earlier trial phases\u003c\/strong\u003e, further evaluating long-term safety, efficacy, and tolerability. Final data and regulatory review are pending.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1536\" data-end=\"1617\"\u003eNo guarantees of outcome can be inferred outside of controlled clinical settings.\u003c\/p\u003e\n\u003chr data-start=\"1619\" data-end=\"1622\"\u003e\n\u003ch3 data-start=\"1624\" data-end=\"1652\"\u003eHow Retatrutide Compares\u003c\/h3\u003e\n\u003cp data-start=\"1653\" data-end=\"1725\"\u003eRetatrutide is often discussed alongside other incretin-based compounds:\u003c\/p\u003e\n\u003cul data-start=\"1727\" data-end=\"2050\"\u003e\n\u003cli data-start=\"1727\" data-end=\"1791\"\u003e\n\u003cp data-start=\"1729\" data-end=\"1791\"\u003e\u003cstrong data-start=\"1729\" data-end=\"1744\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts primarily as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1765\" data-end=\"1791\"\u003eGLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1792\" data-end=\"1875\"\u003e\n\u003cp data-start=\"1794\" data-end=\"1875\"\u003e\u003cstrong data-start=\"1794\" data-end=\"1809\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1815\" data-end=\"1831\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1848\" data-end=\"1875\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1876\" data-end=\"2050\"\u003e\n\u003cp data-start=\"1878\" data-end=\"2050\"\u003e\u003cstrong data-start=\"1878\" data-end=\"1893\"\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1899\" data-end=\"1917\"\u003etriple agonist\u003c\/strong\u003e, additionally engaging the\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1945\" data-end=\"1966\"\u003eglucagon receptor\u003c\/strong\u003e, which differentiates its investigational profile from earlier-generation compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2052\" data-end=\"2055\"\u003e\n\u003ch3 data-start=\"2057\" data-end=\"2082\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-start=\"2083\" data-end=\"2441\"\u003e\n\u003cli data-start=\"2083\" data-end=\"2145\"\u003e\n\u003cp data-start=\"2085\" data-end=\"2145\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2115\" data-end=\"2145\"\u003elyophilised peptide format\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2212\" data-end=\"2265\"\u003e\n\u003cp data-start=\"2214\" data-end=\"2265\"\u003eRetatrutide remains an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2237\" data-end=\"2265\"\u003einvestigational compound\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2266\" data-end=\"2367\"\u003e\n\u003cp data-start=\"2268\" data-end=\"2367\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2288\" data-end=\"2320\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2368\" data-end=\"2441\"\u003e\n\u003cp data-start=\"2370\" data-end=\"2441\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2443\" data-end=\"2446\"\u003e\n\u003ch3 data-start=\"2448\" data-end=\"2481\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2482\" data-end=\"2588\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2522\" data-end=\"2550\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-start=\"2590\" data-end=\"3029\"\u003e\n\u003cli data-start=\"2590\" data-end=\"2671\"\u003e\n\u003cp data-start=\"2592\" data-end=\"2671\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2672\" data-end=\"2748\"\u003e\n\u003cp data-start=\"2674\" data-end=\"2748\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2749\" data-end=\"2859\"\u003e\n\u003cp data-start=\"2751\" data-end=\"2859\"\u003eYou understand that retatrutide is\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2786\" data-end=\"2806\"\u003enot yet approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand remains subject to ongoing clinical evaluation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2860\" data-end=\"2943\"\u003e\n\u003cp data-start=\"2862\" data-end=\"2943\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2882\" data-end=\"2941\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2944\" data-end=\"3029\"\u003e\n\u003cp data-start=\"2946\" data-end=\"3029\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2950\" data-end=\"3029\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251195478129,"sku":null,"price":1600.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18125932.png?v=1779101875"},{"product_id":"hd-labs-retatrutide-32mg-pen","title":"HD Labs Retatrutide 32mg Pen","description":"\u003cp data-end=\"617\" data-start=\"379\"\u003eRetatrutide is a peptide currently under advanced clinical investigation for its activity across multiple metabolic pathways. It is designed to act on\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"614\" data-start=\"549\"\u003ethree key receptors involved in glucose and energy regulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul data-end=\"731\" data-start=\"618\"\u003e\n\u003cli data-end=\"653\" data-start=\"618\"\u003e\n\u003cp data-end=\"653\" data-start=\"620\"\u003eGLP-1 (glucagon-like peptide-1)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"708\" data-start=\"654\"\u003e\n\u003cp data-end=\"708\" data-start=\"656\"\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"731\" data-start=\"709\"\u003e\n\u003cp data-end=\"731\" data-start=\"711\"\u003eGlucagon receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"927\" data-start=\"733\"\u003eThrough this\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"774\" data-start=\"746\"\u003etriple-agonist mechanism\u003c\/strong\u003e, retatrutide has been studied for its effects on insulin secretion, regulation of glucose production, gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003chr data-end=\"932\" data-start=\"929\"\u003e\n\u003ch3 data-end=\"959\" data-start=\"934\"\u003eClinical Trial Status\u003c\/h3\u003e\n\u003cp data-end=\"1077\" data-start=\"960\"\u003eAs of\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"974\" data-start=\"966\"\u003e2025\u003c\/strong\u003e, retatrutide remains\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1052\" data-start=\"996\"\u003eunder investigation and is not yet formally approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor general medical use.\u003c\/p\u003e\n\u003cul data-end=\"1534\" data-start=\"1079\"\u003e\n\u003cli data-end=\"1280\" data-start=\"1079\"\u003e\n\u003cp data-end=\"1280\" data-start=\"1081\"\u003e\u003cstrong data-end=\"1109\" data-start=\"1081\"\u003ePhase 2 clinical studies\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereported significant outcomes, with participants experiencing an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1245\" data-start=\"1175\"\u003eaverage body-weight reduction of approximately 24.2% over 48 weeks\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eunder controlled trial conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1534\" data-start=\"1281\"\u003e\n\u003cp data-end=\"1534\" data-start=\"1283\"\u003e\u003cstrong data-end=\"1310\" data-start=\"1283\"\u003ePhase 3 clinical trials\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare ongoing and have reported\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1422\" data-start=\"1341\"\u003econtinued, clinically meaningful effects consistent with earlier trial phases\u003c\/strong\u003e, further evaluating long-term safety, efficacy, and tolerability. Final data and regulatory review are pending.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1617\" data-start=\"1536\"\u003eNo guarantees of outcome can be inferred outside of controlled clinical settings.\u003c\/p\u003e\n\u003chr data-end=\"1622\" data-start=\"1619\"\u003e\n\u003ch3 data-end=\"1652\" data-start=\"1624\"\u003eHow Retatrutide Compares\u003c\/h3\u003e\n\u003cp data-end=\"1725\" data-start=\"1653\"\u003eRetatrutide is often discussed alongside other incretin-based compounds:\u003c\/p\u003e\n\u003cul data-end=\"2050\" data-start=\"1727\"\u003e\n\u003cli data-end=\"1791\" data-start=\"1727\"\u003e\n\u003cp data-end=\"1791\" data-start=\"1729\"\u003e\u003cstrong data-end=\"1744\" data-start=\"1729\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts primarily as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1791\" data-start=\"1765\"\u003eGLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1875\" data-start=\"1792\"\u003e\n\u003cp data-end=\"1875\" data-start=\"1794\"\u003e\u003cstrong data-end=\"1809\" data-start=\"1794\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1831\" data-start=\"1815\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1875\" data-start=\"1848\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2050\" data-start=\"1876\"\u003e\n\u003cp data-end=\"2050\" data-start=\"1878\"\u003e\u003cstrong data-end=\"1893\" data-start=\"1878\"\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1917\" data-start=\"1899\"\u003etriple agonist\u003c\/strong\u003e, additionally engaging the\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1966\" data-start=\"1945\"\u003eglucagon receptor\u003c\/strong\u003e, which differentiates its investigational profile from earlier-generation compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2055\" data-start=\"2052\"\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2145\" data-start=\"2085\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2145\" data-start=\"2115\"\u003epre-mixed pen format\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2265\" data-start=\"2212\"\u003e\n\u003cp data-end=\"2265\" data-start=\"2214\"\u003eRetatrutide remains an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2265\" data-start=\"2237\"\u003einvestigational compound\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2367\" data-start=\"2266\"\u003e\n\u003cp data-end=\"2367\" data-start=\"2268\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2859\" data-start=\"2749\"\u003e\n\u003cp data-end=\"2859\" data-start=\"2751\"\u003eYou understand that retatrutide is\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2806\" data-start=\"2786\"\u003enot yet approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand remains subject to ongoing clinical evaluation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251196133489,"sku":null,"price":2100.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18130123.png?v=1779101986"},{"product_id":"hd-labs-ghk-cu-100mg","title":"HD Labs GHK-CU 100mg","description":"\u003cp\u003eGHK-Cu 100mg (\u003ca href=\"https:\/\/en.wikipedia.org\/wiki\/Copper_peptide_GHK-Cu\"\u003eCopper Tripeptide-1\u003c\/a\u003e) is a naturally occurring copper-binding peptide widely studied for its regenerative and protective properties, particularly in skin, hair, and connective tissue health. GHK-Cu 50 is a research-grade peptide.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIndications \u0026amp; Use of GHK CU 100mg Vial\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eGHK-Cu has been observed in research to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003eSupport \u003cb\u003eskin regeneration\u003c\/b\u003e, elasticity, and collagen synthesis\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eEnhance \u003cb\u003ehair growth\u003c\/b\u003e and reduce follicular inflammation\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eImprove \u003cb\u003enail strength and resilience\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eExhibit \u003cb\u003eanti-inflammatory\u003c\/b\u003e and \u003cb\u003ewound healing\u003c\/b\u003e properties\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003ePromote overall \u003cb\u003etissue repair and cellular renewal\u003c\/b\u003e\u003cb\u003e\u003cbr\u003e\u003c\/b\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cb\u003eMechanism of Action\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eGHK-Cu functions by binding copper ions and modulating several biological processes. It is known to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eUpregulate genes associated with tissue repair\u003c\/b\u003e, collagen production, and anti-aging\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eDownregulate pro-inflammatory cytokines\u003c\/b\u003e and oxidative stress markers\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eStimulate stem cell activity and \u003cb\u003eangiogenesis\u003c\/b\u003e (formation of new blood vessels)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eActivate \u003cb\u003eTGF-β and integrin pathways\u003c\/b\u003e, contributing to faster healing and skin renewal\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIts ability to communicate with multiple cell types and influence gene expression sets it apart from other peptides in the regenerative and cosmetic research fields.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePossible Side Effects of GHK CU 100mg Vial Peptide\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGHK-Cu is generally well-tolerated in research settings. Potential side effects observed in limited studies include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003eLocal irritation at injection site (redness, itching, swelling)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eTemporary fatigue or light-headedness\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eAllergic reaction (rare)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eCopper overload symptoms if used in excessive doses or combined with other copper-containing agents\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cb\u003eContraindications\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003eKnown \u003cb\u003ehypersensitivity to copper compounds or peptides\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eExisting \u003cb\u003ecopper metabolism disorders\u003c\/b\u003e (e.g., Wilson’s disease)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eUse with caution in subjects with \u003cb\u003eliver or kidney impairment\u003c\/b\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2145\" data-start=\"2085\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2145\" data-start=\"2115\"\u003elyophilised peptide format\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2367\" data-start=\"2266\"\u003e\n\u003cp data-end=\"2367\" data-start=\"2268\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43253104869489,"sku":null,"price":850.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-19094216.png?v=1779176513"},{"product_id":"hd-labs-tirzepatide-30mg-vial","title":"HD Labs Tirzepatide 30mg Vial","description":"\u003cp data-end=\"620\" data-start=\"440\"\u003eTirzepatide is a peptide studied extensively for its activity across key metabolic and incretin pathways. It functions as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"608\" data-start=\"583\"\u003edual receptor agonist\u003c\/strong\u003e, acting on:\u003c\/p\u003e\n\u003cul data-end=\"736\" data-start=\"622\"\u003e\n\u003cli data-end=\"669\" data-start=\"622\"\u003e\n\u003cp data-end=\"669\" data-start=\"624\"\u003e\u003cstrong data-end=\"669\" data-start=\"624\"\u003eGLP-1 (glucagon-like peptide-1) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"736\" data-start=\"670\"\u003e\n\u003cp data-end=\"736\" data-start=\"672\"\u003e\u003cstrong data-end=\"736\" data-start=\"672\"\u003eGIP (glucose-dependent insulinotropic polypeptide) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"939\" data-start=\"738\"\u003eThrough this dual mechanism, tirzepatide has been investigated for its effects on insulin secretion, regulation of hepatic glucose production, delayed gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003cp data-end=\"1136\" data-start=\"941\"\u003eThis product is supplied as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1005\" data-start=\"971\"\u003e30 mg lyophilised peptide vial\u003c\/strong\u003e, intended for purchasers who have independently researched the compound and are operating under appropriate professional guidance.\u003c\/p\u003e\n\u003chr data-end=\"1141\" data-start=\"1138\"\u003e\n\u003ch3 data-end=\"1182\" data-start=\"1143\"\u003eClinical Trial Evidence (Phase 3)\u003c\/h3\u003e\n\u003cp data-end=\"1279\" data-start=\"1183\"\u003eTirzepatide has undergone extensive\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1250\" data-start=\"1219\"\u003ePhase 3 clinical evaluation\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ein large, controlled trials.\u003c\/p\u003e\n\u003cul data-end=\"1735\" data-start=\"1281\"\u003e\n\u003cli data-end=\"1563\" data-start=\"1281\"\u003e\n\u003cp data-end=\"1563\" data-start=\"1283\"\u003eIn Phase 3 studies conducted under controlled conditions, tirzepatide demonstrated\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1421\" data-start=\"1366\"\u003esubstantial and sustained reductions in body weight\u003c\/strong\u003e, with participants achieving\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1524\" data-start=\"1451\"\u003eaverage weight reductions of up to approximately 22–23% over 72 weeks\u003c\/strong\u003e, depending on dose and study protocol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1735\" data-start=\"1564\"\u003e\n\u003cp data-end=\"1735\" data-start=\"1566\"\u003ePhase 3 programmes also evaluated long-term safety, tolerability, and metabolic outcomes, forming the basis for subsequent regulatory approvals in certain jurisdictions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1882\" data-start=\"1737\"\u003eOutcomes observed in clinical trials are dependent on controlled protocols and\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1881\" data-start=\"1816\"\u003edo not guarantee similar results outside of clinical settings\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-end=\"1887\" data-start=\"1884\"\u003e\n\u003ch3 data-end=\"1919\" data-start=\"1889\"\u003eHow Tirzepatide Compares\u003c\/h3\u003e\n\u003cp data-end=\"1991\" data-start=\"1920\"\u003eTirzepatide is often discussed alongside other incretin-based peptides:\u003c\/p\u003e\n\u003cul data-end=\"2233\" data-start=\"1993\"\u003e\n\u003cli data-end=\"2057\" data-start=\"1993\"\u003e\n\u003cp data-end=\"2057\" data-start=\"1995\"\u003e\u003cstrong data-end=\"2010\" data-start=\"1995\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efunctions as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2057\" data-start=\"2026\"\u003eGLP-1 receptor agonist only\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2141\" data-start=\"2058\"\u003e\n\u003cp data-end=\"2141\" data-start=\"2060\"\u003e\u003cstrong data-end=\"2075\" data-start=\"2060\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2097\" data-start=\"2081\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2141\" data-start=\"2114\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2233\" data-start=\"2142\"\u003e\n\u003cp data-end=\"2233\" data-start=\"2144\"\u003eThis dual activity differentiates tirzepatide from earlier single-pathway GLP-1 compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2238\" data-start=\"2235\"\u003e\n\u003ch3 data-end=\"2267\" data-start=\"2240\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2628\" data-start=\"2268\"\u003e\n\u003cli data-end=\"2314\" data-start=\"2268\"\u003e\n\u003cp data-end=\"2314\" data-start=\"2270\"\u003eSupplied in\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2312\" data-start=\"2282\"\u003elyophilised peptide format\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2377\" data-start=\"2315\"\u003e\n\u003cp data-end=\"2377\" data-start=\"2317\"\u003eRequires reconstitution \u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2551\" data-start=\"2448\"\u003e\n\u003cp data-end=\"2551\" data-start=\"2450\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2502\" data-start=\"2470\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2628\" data-start=\"2552\"\u003e\n\u003cp data-end=\"2628\" data-start=\"2554\"\u003eClinical trial results may not reflect individual or real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2633\" data-start=\"2630\"\u003e\n\u003ch3 data-end=\"2670\" data-start=\"2635\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2777\" data-start=\"2671\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2739\" data-start=\"2711\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3207\" data-start=\"2779\"\u003e\n\u003cli data-end=\"2854\" data-start=\"2779\"\u003e\n\u003cp data-end=\"2854\" data-start=\"2781\"\u003eYou have independently researched tirzepatide and its regulatory status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2948\" data-start=\"2855\"\u003e\n\u003cp data-end=\"2948\" data-start=\"2857\"\u003eYou have consulted, or will consult, a qualified healthcare professional prior to any use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3035\" data-start=\"2949\"\u003e\n\u003cp data-end=\"3035\" data-start=\"2951\"\u003eYou understand that clinical trial outcomes do not constitute guarantees of effect\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3121\" data-start=\"3036\"\u003e\n\u003cp data-end=\"3121\" data-start=\"3038\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3119\" data-start=\"3058\"\u003eno medical advice, dosing guidance, or therapeutic claims\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3207\" data-start=\"3122\"\u003e\n\u003cp data-end=\"3207\" data-start=\"3124\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3207\" data-start=\"3128\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43253107228785,"sku":null,"price":1400.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-19094943.png?v=1779176887"},{"product_id":"hd-labs-semaglutide-10mg-vial","title":"HD Labs Semaglutide 10mg Vial","description":"\u003cp data-start=\"404\" data-end=\"653\"\u003eSemaglutide is a synthetic peptide analogue extensively studied for its role in\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"484\" data-end=\"524\"\u003eincretin-mediated metabolic pathways\u003c\/strong\u003e. It functions as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"544\" data-end=\"596\"\u003eGLP-1 (glucagon-like peptide-1) receptor agonist\u003c\/strong\u003e, a class of compounds investigated for their effects on:\u003c\/p\u003e\n\u003cul data-start=\"655\" data-end=\"809\"\u003e\n\u003cli data-start=\"655\" data-end=\"694\"\u003e\n\u003cp data-start=\"657\" data-end=\"694\"\u003eGlucose-dependent insulin secretion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"695\" data-end=\"739\"\u003e\n\u003cp data-start=\"697\" data-end=\"739\"\u003eRegulation of hepatic glucose production\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"740\" data-end=\"768\"\u003e\n\u003cp data-start=\"742\" data-end=\"768\"\u003eDelayed gastric emptying\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"769\" data-end=\"809\"\u003e\n\u003cp data-start=\"771\" data-end=\"809\"\u003eAppetite-related signalling pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"811\" data-end=\"1013\"\u003eThis product is supplied as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"841\" data-end=\"875\"\u003e10 mg lyophilised peptide vial\u003c\/strong\u003e, intended for informed purchasers who have independently researched the compound and have consulted appropriate healthcare professionals.\u003c\/p\u003e\n\u003chr data-start=\"1015\" data-end=\"1018\"\u003e\n\u003ch3 data-start=\"1020\" data-end=\"1059\"\u003eClinical Trial Evidence (Phase 3)\u003c\/h3\u003e\n\u003cp data-start=\"1060\" data-end=\"1153\"\u003eSemaglutide has been evaluated in multiple large-scale\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1115\" data-end=\"1152\"\u003ePhase 3 clinical trial programmes\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cul data-start=\"1155\" data-end=\"1645\"\u003e\n\u003cli data-start=\"1155\" data-end=\"1461\"\u003e\n\u003cp data-start=\"1157\" data-end=\"1461\"\u003eIn Phase 3 trials conducted under controlled conditions, semaglutide demonstrated\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1239\" data-end=\"1304\"\u003eclinically meaningful and sustained reductions in body weight\u003c\/strong\u003e, with participants in certain studies achieving\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1353\" data-end=\"1420\"\u003eaverage weight reductions of approximately 14–15% over 68 weeks\u003c\/strong\u003e, depending on study design and protocol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1462\" data-end=\"1645\"\u003e\n\u003cp data-start=\"1464\" data-end=\"1645\"\u003ePhase 3 programmes also assessed long-term safety, tolerability, and metabolic outcomes, and these data formed the basis for regulatory review and approval in various jurisdictions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1647\" data-end=\"1784\"\u003eResults observed in clinical trials reflect\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1691\" data-end=\"1727\"\u003econtrolled research environments\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand do not guarantee similar outcomes in other settings.\u003c\/p\u003e\n\u003chr data-start=\"1786\" data-end=\"1789\"\u003e\n\u003ch3 data-start=\"1791\" data-end=\"1821\"\u003eHow Semaglutide Compares\u003c\/h3\u003e\n\u003cp data-start=\"1822\" data-end=\"1893\"\u003eSemaglutide is often discussed alongside newer incretin-based peptides:\u003c\/p\u003e\n\u003cul data-start=\"1895\" data-end=\"2120\"\u003e\n\u003cli data-start=\"1895\" data-end=\"1964\"\u003e\n\u003cp data-start=\"1897\" data-end=\"1964\"\u003e\u003cstrong data-start=\"1897\" data-end=\"1912\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1923\" data-end=\"1964\"\u003esingle-pathway GLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1965\" data-end=\"2038\"\u003e\n\u003cp data-start=\"1967\" data-end=\"2038\"\u003e\u003cstrong data-start=\"1967\" data-end=\"1982\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003etargets both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1996\" data-end=\"2023\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e(dual agonist)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2039\" data-end=\"2120\"\u003e\n\u003cp data-start=\"2041\" data-end=\"2120\"\u003e\u003cstrong data-start=\"2041\" data-end=\"2056\"\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eadditionally engages the\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2082\" data-end=\"2103\"\u003eglucagon receptor\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e(triple agonist)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2122\" data-end=\"2207\"\u003eSemaglutide represents an established GLP-1–based compound within this broader class.\u003c\/p\u003e\n\u003ch3 data-start=\"2214\" data-end=\"2241\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003chr data-start=\"2052\" data-end=\"2055\"\u003e\n\u003ch3 data-start=\"2057\" data-end=\"2082\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-start=\"2083\" data-end=\"2441\"\u003e\n\u003cli data-start=\"2083\" data-end=\"2145\"\u003e\n\u003cp data-start=\"2085\" data-end=\"2145\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2115\" data-end=\"2145\"\u003elyophilised peptide format\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2266\" data-end=\"2367\"\u003e\n\u003cp data-start=\"2268\" data-end=\"2367\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2288\" data-end=\"2320\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2368\" data-end=\"2441\"\u003e\n\u003cp data-start=\"2370\" data-end=\"2441\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2443\" data-end=\"2446\"\u003e\n\u003ch3 data-start=\"2448\" data-end=\"2481\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2482\" data-end=\"2588\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2522\" data-end=\"2550\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-start=\"2590\" data-end=\"3029\"\u003e\n\u003cli data-start=\"2590\" data-end=\"2671\"\u003e\n\u003cp data-start=\"2592\" data-end=\"2671\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2672\" data-end=\"2748\"\u003e\n\u003cp data-start=\"2674\" data-end=\"2748\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2860\" data-end=\"2943\"\u003e\n\u003cp data-start=\"2862\" data-end=\"2943\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2882\" data-end=\"2941\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2944\" data-end=\"3029\"\u003e\n\u003cp data-start=\"2946\" data-end=\"3029\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2950\" data-end=\"3029\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43253108801649,"sku":null,"price":1150.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-19095232.png?v=1779177054"},{"product_id":"hd-labs-tirzepatide-30mg-pen-metabolic-peptide-support","title":"HD Labs | Tirzepatide 30mg Pen | Metabolic Peptide Support","description":"\u003cp data-start=\"293\" data-end=\"656\"\u003e\u003cstrong\u003eHD Labs Tirzepatide 30mg Pen\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a research peptide supplied in a prefilled delivery system designed for precision and consistent handling in laboratory settings. It is associated with dual agonist activity at GLP-1 and GIP receptors, which are studied for their roles in metabolic signaling, appetite regulation, and glucose balance.\u003c\/p\u003e\n\u003cp data-start=\"658\" data-end=\"873\"\u003eThis product is intended strictly for research use only. It is not approved for human consumption or therapeutic use. All handling should follow appropriate laboratory standards and applicable regulatory guidelines.\u003c\/p\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43302108070001,"sku":null,"price":1950.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-06-03143458.png?v=1780489984"},{"product_id":"hd-labs-semaglutide-10mg-pen","title":"HD Labs | Semaglutide 10mg Pen","description":"","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43302118916209,"sku":null,"price":1550.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-06-03143709.png?v=1780490188"}],"url":"https:\/\/vitalitylab.co.za\/collections\/hd-labs.oembed","provider":"Vitality Lab","version":"1.0","type":"link"}